AZ v Commission: Losec anti-competitive case enters final stages
This article was originally published in Scrip
Executive Summary
On 15 May an advocate general of the Court of Justice of the European Union (CJEU) will deliver an opinion in the long-running case pitting AstraZeneca against the European Commission over the company's alleged anti-competitive behaviour regarding its anti-ulcer drug Losec.